362 related articles for article (PubMed ID: 11265258)
1. Antigenic specificity of anti-neutrophil cytoplasmic antibody.
Fu HL; Hsu TC; Chang CC; Tsay GJ
J Formos Med Assoc; 2001 Jan; 100(1):35-9. PubMed ID: 11265258
[TBL] [Abstract][Full Text] [Related]
2. Contribution of immunofluorescence to the identification and characterization of anti-neutrophil cytoplasmic autoantibodies. The role of different fixatives.
Radice A; Vecchi M; Bianchi MB; Sinico RA
Clin Exp Rheumatol; 2000; 18(6):707-12. PubMed ID: 11138332
[TBL] [Abstract][Full Text] [Related]
3. Detection rate and antigenic specificities of antineutrophil cytoplasmic antibodies in chinese patients with clinically suspected vasculitis.
Xin G; Zhao MH; Wang HY
Clin Diagn Lab Immunol; 2004 May; 11(3):559-62. PubMed ID: 15138182
[TBL] [Abstract][Full Text] [Related]
4. Anti-neutrophil cytoplasmic antibodies in 566 European patients with systemic lupus erythematosus: prevalence, clinical associations and correlation with other autoantibodies. European Concerted Action on the Immunogenetics of SLE.
Galeazzi M; Morozzi G; Sebastiani GD; Bellisai F; Marcolongo R; Cervera R; De Ramòn Garrido E; Fernandez-Nebro A; Houssiau F; Jedryka-Goral A; Mathieu A; Papasteriades C; Piette JC; Scorza R; Smolen J
Clin Exp Rheumatol; 1998; 16(5):541-6. PubMed ID: 9779300
[TBL] [Abstract][Full Text] [Related]
5. Escherichia coli and Proteus mirabilis inhibit the perinuclear but not the circulating antineutrophil cytoplasmic antibody reaction.
Yang P; Danielsson D; Järnerot G
Scand J Gastroenterol; 1998 May; 33(5):529-34. PubMed ID: 9648994
[TBL] [Abstract][Full Text] [Related]
6. Immunoglobulin isotypes of anti-myeloperoxidase and anti-lactoferrin antibodies in patients with collagen diseases.
Chikazawa H; Nishiya K; Matsumori A; Hashimoto K
J Clin Immunol; 2000 Jul; 20(4):279-86. PubMed ID: 10939715
[TBL] [Abstract][Full Text] [Related]
7. Autoantibodies to proteinase 3 and myeloperoxidase in systemic sclerosis.
Ruffatti A; Sinico RA; Radice A; Ossi E; Cozzi F; Tonello M; Grypiotis P; Todesco S
J Rheumatol; 2002 May; 29(5):918-23. PubMed ID: 12022350
[TBL] [Abstract][Full Text] [Related]
8. Low seroprevalence and poor specificity of antineutrophil cytoplasmic antibodies in tuberculosis.
Teixeira L; Mahr A; Jaureguy F; Noël LH; Nunes H; Lefort A; Barry S; Deny P; Guillevin L
Rheumatology (Oxford); 2005 Feb; 44(2):247-50. PubMed ID: 15546964
[TBL] [Abstract][Full Text] [Related]
9. Antineutrophil cytoplasmic antibodies in synovial fluid and in serum of patients with rheumatoid arthritis and other types of synovitis.
Afeltra A; Sebastiani GD; Galeazzi M; Caccavo D; Ferri GM; Marcolongo R; Bonomo L
J Rheumatol; 1996 Jan; 23(1):10-5. PubMed ID: 8838502
[TBL] [Abstract][Full Text] [Related]
10. A comparison of commercial and in-house ELISAs for antineutrophil cytoplasmic antibodies directed against proteinase 3 and myeloperoxidase.
Pollock W; Dunster K; Rolland JM; Koh H; Savige J
Pathology; 1999 Feb; 31(1):38-43. PubMed ID: 10212921
[TBL] [Abstract][Full Text] [Related]
11. Antineutrophil cytoplasmic antibodies in Japanese patients with inflammatory bowel disease: prevalence and recognition of putative antigens.
Sugi K; Saitoh O; Matsuse R; Tabata K; Uchida K; Kojima K; Nakagawa K; Tanaka S; Teranishi T; Hirata I; Katsu K
Am J Gastroenterol; 1999 May; 94(5):1304-12. PubMed ID: 10235211
[TBL] [Abstract][Full Text] [Related]
12. [Prevalence and specificity of antineutrophil cytoplasmic antibodies (ANCA) in connective tissue diseases].
Puszczewicz M; Zimmermann-Górska I; Białkowska-Puszczewicz G; Tuchocka A
Pol Arch Med Wewn; 2003 Jan; 109(1):35-41. PubMed ID: 12879764
[TBL] [Abstract][Full Text] [Related]
13. Antibodies to selected minor target antigens in patients with anti-neutrophil cytoplasmic antibodies (ANCA).
Talor MV; Stone JH; Stebbing J; Barin J; Rose NR; Burek CL
Clin Exp Immunol; 2007 Oct; 150(1):42-8. PubMed ID: 17614969
[TBL] [Abstract][Full Text] [Related]
14. Clinical spectrum associated with ANCA of defined antigen specificities in 98 selected patients.
Geffriaud-Ricouard C; Noël LH; Chauveau D; Houhou S; Grünfeld JP; Lesavre P
Clin Nephrol; 1993 Mar; 39(3):125-36. PubMed ID: 7681736
[TBL] [Abstract][Full Text] [Related]
15. [Antineutrophil cytoplasmic antibody associated vasculitis induced by antithyroid agents].
Guo XH; Zhao MH; Gao Y; Wang SF; Gao Y
Zhonghua Yi Xue Za Zhi; 2003 Jun; 83(11):932-5. PubMed ID: 12899790
[TBL] [Abstract][Full Text] [Related]
16. Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus.
Spronk PE; Bootsma H; Horst G; Huitema MG; Limburg PC; Tervaert JW; Kallenberg CG
Br J Rheumatol; 1996 Jul; 35(7):625-31. PubMed ID: 8670594
[TBL] [Abstract][Full Text] [Related]
17. Occurrence of antineutrophil cytoplasmic and antineutrophil (peri)nuclear antibodies in rheumatoid arthritis.
Bosch X; Llena J; Collado A; Font J; Mirapeix E; Ingelmo M; Muñoz-Gómez J; Urbano-Márquez A
J Rheumatol; 1995 Nov; 22(11):2038-45. PubMed ID: 8596141
[TBL] [Abstract][Full Text] [Related]
18. A review of immunofluorescent patterns associated with antineutrophil cytoplasmic antibodies (ANCA) and their differentiation from other antibodies.
Savige JA; Paspaliaris B; Silvestrini R; Davies D; Nikoloutsopoulos T; Sturgess A; Neil J; Pollock W; Dunster K; Hendle M
J Clin Pathol; 1998 Aug; 51(8):568-75. PubMed ID: 9828813
[TBL] [Abstract][Full Text] [Related]
19. Indirect immunofluorescence (IIF) of normal washed peripheral blood cells to demonstrate antineutrophil cytoplasmic antibodies (ANCA).
Paspaliaris B; Pamio M; Savige J
J Clin Pathol; 2000 Oct; 53(10):774-7. PubMed ID: 11064672
[TBL] [Abstract][Full Text] [Related]
20. A novel strategy with combined assays for detection of anti-neutrophil cytoplasmic antibody (ANCA) in clinically ANCA-negative granulomatosis with polyangiitis patients.
Tateyama K; Kodama S; Kishibe K; Harabuchi Y; Suzuki M
Auris Nasus Larynx; 2017 Dec; 44(6):735-741. PubMed ID: 28666565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
